There Are Now 50 Psychedelics Companies Listed In The U.S. – Here They Are
Today, 8:04 AM
Just two years ago, the psychedelics sector was a small research space reserved for academics and extremely forward-thinking investors.
Psyched: Seattle Decriminalizes Psychedelics, Psilocybin Increases Emotions From Music, Novamind’s Palliative Care Program
Today, 8:04 AM
The Week In Psychedelics
Seattle Decriminalizes Psychedelics Along With California City
Psyched: Elon Musk Discusses Psychedelics, Delix Raises $70M, MindCure To Study MDMA In Female Sexual Dysfunction
Today, 8:04 AM
The Week In Psychedelics:
These OTC Securities Had the Most Trading Activity in June
Today, 8:04 AM
Photo by Cris Ovalle on Unsplash
OTC Markets trading volume was still led by cryptocurrencies and cannabis for the month of June, but many other securities shined comparatively as volumes in crypto and cannabis slowed.
Psyched: GH Research Debuts on Nasdaq, Compass Reaches Psilocybin Research Milestone, Maxim Gives BUY Rating to 10 Psychedelics Companies
Today, 8:04 AM
Irish 5-MeO-DMT Company GH Research Debuts On Nasdaq
GH Research, a Dublin-based company studying the potential of 5-MeO-DMT for the treatment of psychiatric and neurological disorders, is now listing its stock on the Nasdaq under the symbol “GHRS.”
Maxim Group Gives Buy Rating To 10 Psychedelic Stocks: Compass, MindMed, Cybin, Field Trip And More
Today, 8:04 AM
Institutional analysts are taking a liking to the industry of medicinal psychedelics. This week, investment bank Maxim Group initiated coverage of companies in the psychedelics space, giving a bullish Buy rating to all 10.